Sinotau (先通医药) Pre-IPO: A Niche Radiopharmaceutical Player
China's Sinotau aims to raise $100 million through a Hong Kong listing with CICC as book runner. We explores its core products, pre-IPO investors,...
462 Views
Hong Kong IPO Analytics - Regular Cornerstone Investors and Track Record
At the beginning of this year, we at Aequitas Research, wrote on IPO analytics of deals across Asia-Pacific from 2016 to 2018. If you have not read...
1.1k Views
Smartkarma: ECM Coverage Weekly Update (7 July 2018)
The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. Hong Kong IPOs has...
653 Views
China Isotope & Radiation IPO: Oligopoly, Visible Growth and High Barrier to Entry
China Isotope & Radiation, the leading radiopharmaceuticals players in China, is raising up to USD 284 million in its listing in Hong Kong. In...
490 Views
No more insights